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ABSTRACT We used the mouse attaching and effacing (A/E) pathogen Citrobacter
rodentium, which models the human A/E pathogens enteropathogenic Escherichia
coli and enterohemorrhagic E. coli (EPEC and EHEC), to temporally resolve intestinal
epithelial cell (IEC) responses and changes to the microbiome during in vivo infec-
tion. We found the host to be unresponsive during the first 3 days postinfection
(DPI), when C. rodentium resides in the caecum. In contrast, at 4 DPI, the day of co-
lonic colonization, despite only sporadic adhesion to the apex of the crypt, we ob-
served robust upregulation of cell cycle and DNA repair processes, which were asso-
ciated with expansion of the crypt Ki67-positive replicative zone, and
downregulation of multiple metabolic processes (including the tricarboxylic acid
[TCA] cycle and oxidative phosphorylation). Moreover, we observed dramatic deple-
tion of goblet and deep crypt secretory cells and an atypical regulation of choles-
terol homeostasis in IECs during early infection, with simultaneous upregulation of
cholesterol biogenesis (e.g., 3-hydroxy-3-methylglutaryl–coenzyme A reductase
[Hmgcr]), import (e.g., low-density lipoprotein receptor [Ldlr]), and efflux (e.g.,
AbcA1). We also detected interleukin 22 (IL-22) responses in IECs (e.g., Reg3) on the
day of colonic colonization, which occurred concomitantly with a bloom of com-
mensal Enterobacteriaceae on the mucosal surface. These results unravel a new par-
adigm in host-pathogen-microbiome interactions, showing for the first time that
sensing a small number of pathogenic bacteria triggers swift intrinsic changes to the
IEC composition and function, in tandem with significant changes to the mucosa-
associated microbiome, which parallel innate immune responses.
IMPORTANCE The mouse pathogen C. rodentium is a widely used model for colonic
infection and has been a major tool in fundamental discoveries in the fields of bac-
terial pathogenesis and mucosal immunology. Despite extensive studies probing
acute C. rodentium infection, our understanding of the early stages preceding the in-
fection climax remains relatively undetailed. To this end, we apply a multiomics ap-
proach to resolve temporal changes to the host and microbiome during early infec-
tion. Unexpectedly, we found immediate and dramatic responses occurring on the
day of colonic infection, both in the host intestinal epithelial cells and in the micro-
biome. Our study suggests changes in cholesterol and carbon metabolism in epithe-
lial cells are instantly induced upon pathogen detection in the colon, corresponding
with a shift to primarily facultative anaerobes constituting the microbiome. This
study contributes to our knowledge of disease pathogenesis and mechanisms of
barrier regulation, which is required for development of novel therapeutics targeting
the intestinal epithelium.
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The intestinal epithelium serves a dual role as it enables nutrient absorption whilesimultaneously providing a barrier to commensal bacteria and pathogens (1).
Constant renewal of the epithelium every 5 to 7 days is enabled by LGR5 stem cells
at the base of the crypts, where they lie intermingled with deep crypt secretory (DCS)
cells called Reg4 cells (2). Transit-amplifying (TA) cells, arising from proliferation and
partial differentiation of LGR5 cells, rapidly divide in the lower half of the crypt a
number of times before arresting their cell cycle and differentiating into mature cell
types as they migrate to the crypt’s upper surface. These differentiated cell types
include absorptive enterocytes, goblet cells, enteroendocrine cells, and tuft cells. In
addition to providing a barrier, intestinal epithelial cells (IECs) also have immunoregu-
latory properties enabling them to detect invading pathogens, e.g., they are able to
express pattern recognition receptors, and subsequently influence development of the
mucosal immune cell response (3).
Citrobacter rodentium, an extracellular mouse pathogen, is a physiologically relevant
model for the human clinical pathogens enteropathogenic Escherichia coli (EPEC) and
enterohemorrhagic E. coli (EHEC), and it has been widely used to probe mucosal
responses to colonic infection (4, 5). Hallmarks of C. rodentium infection include tissue
regeneration via colonic crypt hyperplasia (CCH), which results from increased ampli-
fication of TA cells in conjunction with inhibition of both anoikis and cell detachment.
(5). Furthermore, the host has been shown to mount a robust nutritional immune
response to C. rodentium infection, manifested by secretion of lipocalin-2 (LCN-2) and
calprotectin (a heterodimer of subunits S100A8 and S100A9), which sequester the trace
minerals Fe (LCN-2) and Mn and Zn (calprotectin) (6).
Following oral inoculation, C. rodentium initially colonizes the cecal patch, a major
lymphoid structure in the cecum, where it adapts to the gut environment (7). We define
these first few days as the establishment phase, during which most of the inoculum
passes straight through the intestinal tract and is shed in the feces (8). C. rodentium
spreads from the cecal patch to the colon at 4 days postinfection (DPI), enabling rapid
bacterial proliferation as it penetrates the mucosa and intimately attaches to IECs,
which we define as the expansion phase. Colonization levels plateau at 108 to 109
CFU/g of feces between 8 to 12 DPI, before bacterial shedding decreases as the
infection starts to clear between 12 to 16 DPI, which we define as the steady-state and
clearance phases, respectively (5, 8). Mice develop colitis during C. rodentium infection
(4), and dysbiosis is induced in the large intestine, resulting in a reduction in the overall
abundance and diversity of commensal bacteria (9).
IECs express the receptor for interleukin 22 (IL-22), which plays an essential role
during C. rodentium infection, as it fortifies the intestinal barrier and restricts the
pathogen to the gut (10). IL-22 also promotes production of antimicrobial peptides
(AMPs), e.g., Reg3 and Reg3, LCN-2, calprotectin, and mucins (11–14). IL-22 is
produced by innate class 3 lymphoid cells (ILC3s) during the establishment and
expansion phases of infection, followed by CD11b Ly6C Ly6G neutrophils (15) and
Th17 and Th22 T cells (16, 17), which contribute to IL-22 production during the
steady-state and clearance phases. Despite IL-22 promoting epithelial regeneration in
a STAT-3-dependent manner, IL-22–/– mice exhibit increased CCH and tissue damage at
peak C. rodentium infection compared to that of wild-type mice (18), suggesting that in
the absence of IL-22 there is an uncoordinated damage repair response to infection.
Furthermore, IL-22 has also been implicated in regulating tight junctions and the
permeability of IECs, including upregulation of the paracellular water and Na channel
Claudin-2 (19, 20).
Recently, we reported that C. rodentium subverts IEC metabolism in order to evade
innate immune responses and establish a favorable niche in the colon (6, 21). Using
multiplex proteomics, we uncovered a significant downregulation of host metabolic
pathways, including gluconeogenesis, lipid metabolism, the tricarboxylic acid (TCA)
cycle and oxidative phosphorylation (OXPHOS), with a simultaneous upregulation of
cell cycle and DNA replication pathways. At this stage, the IECs seemed to rely on
aerobic glycolysis, fueled by a robust upregulation of the basolateral glucose trans-
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porter Slc5A9 (6). Presumably, this metabolic reprogramming occurs to meet the
increased cellular energetic demands mediating tissue repair responses to the infec-
tion. Furthermore, our proteomics data, validated with a fecal cholesterol quantification
assay, highlighted upregulation of both cholesterol biogenesis and efflux/influx path-
ways (6), processes which are usually regulated antagonistically. These observations are
consistent with cholesterol being an essential ingredient of new membranes formed in
proliferating cells and having a role in innate immunity.
Importantly, while studies of pathogen-host interactions are usually conducted at
the acute phase of the infection, little is currently known about the temporal host
responses culminating before the pathogen burden peaks. The aim of this study was to
temporally resolve IEC and microbiome responses at the expansion phase of C. roden-
tium infection (4 and 6 DPI). This revealed a dramatic reprogramming of the crypt
cellular composition, metabolism, and DNA replication and repair immediately as the
pathogen starts to colonize the colon, which coincided with the expansion of mucosa-
associated Enterobacteriaceae.
RESULTS
Sporadic mucosal association of C. rodentium at the onset of colonic coloniza-
tion. We recently reported IEC responses to C. rodentium at the steady-state phase of
the infection (8 DPI), including reprogramming of bioenergetics and metabolism (6).
Here, we aimed to track the progression of C. rodentium infection-induced alterations
to the gut microenvironment, using multiplexed quantitative proteomics, transcrip-
tomics, enzyme-linked immunosorbent assay (ELISA), and 16S rRNA gene sequencing.
We first performed temporal profiling of C. rodentium shedding and tissue associ-
ation during the expansion phase of infection. This revealed that shedding reached an
average of 6.5 107 CFU/g by 4 DPI and 6.9 108 CFU/g by 6 DPI (Fig. 1A). Impor-
tantly, we recorded larger standard errors of the means at 2 to 4 DPI than at 5 and 6
DPI, suggesting that while migrating from the cecum to the colon, C. rodentium is more
sensitive to variable host environments in individual mice (e.g., the composition of the
microbiota) but is able to adapt once initial colon colonization has occurred, thus
reaching homogenous levels of colonization from 5 DPI onwards. Comparing tissue
distributions of C. rodentium at 4 DPI (i.e., on the day of colonic colonization) and 6 DPI
(i.e., the intermediate time between the expansion and steady-state phases) by immu-
nohistochemistry revealed distinct differences in bacterial abundance and distribution
(Fig. 1B). Notably, no C. rodentium was detected in colonic sections at 3 DPI (see Fig. S1
in the supplemental material). While binding of C. rodentium to the colonic mucosa was
scarce and highly varied between different mice at 4 DPI, a uniform distribution of the
pathogen along the entire colonic mucosa was seen at 6 DPI (Fig. S1). These data
suggest that despite 3 107 CFU/g being shed in the feces at 3 DPI, C. rodentium is not
yet visibly detected in the large intestine; however, on the 4th day, C. rodentium is
seeded in the colon, which is followed by rapid expansion.
C. rodentium triggers rapid polarization of metabolic and cell proliferation
processes. In order to determine the temporal impact of C. rodentium infection on IECs
during the expansion phase, we performed proteomic analysis of colonic IECs isolated
from C. rodentium-infected mice at 4 and 6 DPI using mock-infected mice as controls.
We included 5 mice per time point and monitored colonization levels up until and
including the day of extraction; mice that did not reach the minimum number of CFU
per gram of stool thresholds (1 107 CFU/g stool by 4 DPI or 1 108 CFU/g stool by
6 DPI) were excluded from further processing to reduce heterogeneity within each
condition (Fig. S2). Protein extracts from IECs enriched from mice within the same
condition of a single biological repeat were pooled at a 1:1 ratio and labeled with
tandem mass tags (TMT) before undergoing liquid chromatography-tandem mass
spectrometry (LC-MS/MS) analysis (Fig. S3A; Table S1). To generate a robust data set,
three biological repeats were included within the same multiplex experiment.
We quantified a total of 10,418 proteins, of which 9,127 were mapped to Mus
musculus and 1,290 to C. rodentium (peptide false-discovery rate [FDR],1%). Statistical
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FIG 1 Sporadic C. rodentium colonization at 4 DPI induces upregulation of the cell cycle and downregulation of metabolic processes. (A) Line graph showing
average numbers of CFU/g feces with standard error of the mean bars over the time course of C. rodentium infection (n 10). (B) Representative images of
immunostaining of C. rodentium (white) and DNA (blue) on colonic sections (n 10) from mock-infected (Mock) or infected mice at 4 DPI or 6 DPI, as indicated.
(Continued on next page)
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analysis considering both the 4 and the 6 DPI data as infected samples identified 587
upregulated and 446 downregulated proteins compared to protein expression in the
mock-infected samples (Fig. S3B). Further analysis of the most significantly changed
proteins upon infection revealed two protein subsets: those that decrease during the
course of infection, which highlighted processes, including carbohydrate and pyruvate
metabolism, as downregulated, and those that increase, which showed upregulation of
processes, including response to stress, DNA replication, and ribosome biogenesis
(Fig. 1C). Bioinformatic analysis of the data set as a whole identified additional enriched
pathways, including significant downregulation of further metabolic processes, such as
the TCA cycle, OXPHOS, propanoate, pyruvate, and starch and glucose metabolism, and
upregulation of cell cycle and DNA repair pathways (mismatch repair, homologous
recombination, and nucleotide excision repair) (Fig. 1D). Unexpectedly, many of these
processes correlate with those identified as significantly altered at the steady-state
phase of infection (6), suggesting that a significant response to pathogen infection is
mounted in IECs during the expansion phase. Interestingly, Forkhead box O3 (FOXO3),
a transcription factor involved in modulating the metabolic state and cellular apoptosis,
was predicted to be significantly inactivated during C. rodentium infection (enrichment
score, 0.31; Benjamini-Hochberg FDR, 8.16E–03), correlating with a previous in vitro
study that showed that C. rodentium infection led to inactivation of FOXO3 in intestinal
epithelia (Fig. S4) (22).
To further resolve temporal changes, one-dimensional (1D) enrichment analysis was
applied to 4 and 6 DPI samples separately, revealing early onset of a number of DNA
repair pathways, with base excision repair specific to 4 DPI only (Fig. 1E). Significant
upregulation of a number of DNA repair pathways at 4 DPI, in addition to upregulation
of cell cycle and DNA replication processes, strongly suggests that proliferation path-
ways are activated even when C. rodentium colonization is low, sporadic, and restricted
to the upper surface of the crypt. While both expansion phase time points show
downregulation of the TCA cycle, the pentose phosphate pathway, and pyruvate
metabolism, only 6 DPI additionally shows upregulation of steroid hormone biosyn-
thesis, suggesting that changes to IEC metabolism are initiated as early as the day of
colonic colonization (4 DPI), but further aspects of metabolism become significantly
affected as pathogen levels in the colon increase. Furthermore, downregulation of the
TCA cycle and OXPHOS suggests a progressive shift of cellular bioenergetics during
infection to aerobic glycolysis, which coincides with an increase in cell proliferation.
On a protein-specific level, among the proteins ranked in the top 100 for most
changed in abundance, we found a number of innate immunity and nutritional
immunity proteins, including matrix metallopeptidase 9 (MMP9), Reg3, Reg3, induc-
ible nitric oxide synthase (iNOS), LCN-2, DMBT1, S100A8, and S100A9 (Fig. 1F). Further-
more, the neutrophil chemoattractant CXCL5, the glucose transporter that fuels glyco-
lysis, Slc5A9, the rate-limiting enzyme in the cholesterol biogenesis pathway, Hmgcr
(3-hydroxy-3-methylglutaryl–coenzyme A reductase), and the basolateral cholesterol
efflux transporter Abca1 were also found among top 100 proteins with significantly
increased abundance during infection. Together, these data show that a significant
change in both the metabolic and proliferative states of IECs is induced on the day of
colonic colonization (4 DPI), coinciding with innate and nutritional immunity responses.
FIG 1 Legend (Continued)
Sections from 4 DPI were highly varied; thus, the image with the average level of C. rodentium staining was selected. Scale bar 500 m. (C) Heat map showing
proteins with significantly altered abundances at 6 DPI compared to abundances in mock-infected mice and filtered for the 30% most altered proteins upon
infection. Scaled abundances for 3 biological repeats of each time point are shown (R1 to R3). Profile plots show significant downregulated proteins in blue
and upregulated proteins in red. The right-most plot shows relative enrichments of named KEGG and GOBP pathways. Fischer exact test FDR,0.05. Benj. Hoch.,
Benjamini-Hochberg. (D) KEGG pathway enrichment analysis. Proteins are ranked according to log2 values on the x axis, with increasingly negative log2FC values
on the far left (blue) to increasingly positive log2FC values during infection on the far right (red). 1D annotation enrichment of KEGG pathways during infection
are highlighted in the heat map on the y axis, with the most downregulated pathways at the top to the most upregulated pathways at the bottom. FDR 
0.05; t test (n 3). (E) Venn diagram showing pathways that are upregulated (red) or downregulated (blue) at 4 DPI, 6 DPI, or both time points of infection.
(F) Heat map of selected proteins from the top 100 proteins when statistically significantly altered abundances are ranked based on the highest fold change
at 6 DPI compared to abundances in mock-infected controls.
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Cholesterol biogenesis and efflux are simultaneously induced at the expansion
phase. In addition to Hmgcr, the other proteins in the cholesterol biogenesis cascade
(Fig. S5A) and the low-density lipoprotein receptor (Ldlr), as well as proprotein con-
vertase subtilisin/kexin type 9 (Pcsk9), which antagonizes Ldlr (Fig. 2A), were found in
increased abundance during the expansion phase of infection compared to their levels
in mock-infected control mice. Both Hmgcr and Ldlr were in significantly higher
abundance at 4 DPI (log2 fold changes [log2FC], 1.53 and 1.11, respectively), with a
FIG 2 Cholesterol homeostasis is perturbed during early infection. (A and B) Log2FCs in infected samples (4 or 6 DPI, as indicated) compared with samples
from mock-infected mice of named SREBP2-induced proteins (A) and LXR-induced proteins (B). The dotted line at log2FC value 0.6 represents the implicated
cutoff for an upregulated protein. (C to H) A qRT-PCR analysis of Hmgcr (C), Ldlr (D), Pcsk9 (E), Abca1 (F), Abcg5 (G), and Idol (H) revealed expression levels in
IECs enriched from mock-infected or C. rodentium-infected colons. Shown are log2FCs in expression levels compared to the average level in mock-infected mice
from the same biological repeat. Statistical significance was determined by Tukey’s multiple-comparison test. *, P  0.05; **, P  0.01; ***, P  0.001; ****,
P  0.0001; ns, not significant.
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more exaggerated increase at 6 DPI (log2FC, 2.04 and1.33, respectively). Uniquely, in
parallel with the increased abundance of proteins involved in cholesterol biogenesis
and import, we found an increase in the cholesterol efflux transporters Abca1 and
Abcg5, with a significant increase in Abca1 protein levels at both 4 DPI and 6 DPI
(log2FC, 1.45 and 2.89, respectively) (Fig. 2B).
While expression of Hmgcr, Ldlr, and Pcsk9 is regulated by the transcription factor
SREBP2, expression of Abca1, Abcg5, and the inducible degrader of the low-density
lipoprotein (LDL) receptor (Idol) is regulated by liver X receptor (LXR), transcription
factors which are considered to be mutually antagonistic (23). In order to determine the
temporal activation of SREBP2 and LXR, we profiled the expression of Ldlr, Pcsk9, Hmgcr,
Abca1, Abcg5, and Idol by quantitative reverse transcription-PCR (qRT-PCR). Unexpect-
edly, unlike with the proteomics data, this revealed that expression of Hmgcr was
significantly downregulated at 6 DPI (Fig. 2C), with no significant change at 4 DPI.
Moreover, no significant change in the expression of Ldlr or Pcsk9 was seen at either
expansion phase time points compared to their expression in mock-infected mice, yet
a significant increase in the expression of Hmgcr, Ldlr, and Pcsk9 was detected at 8 DPI
(Fig. 2D and E). This apparent discrepancy between the proteome and transcriptome at
4 and 6 DPI may reflect changes to the degradation pathway of these proteins during
infection or suggest that there is a store of these mRNAs in P bodies. In contrast,
expression of Abca1 showed a temporal increase during the course of infection, with a
tendency toward upregulation on 4 DPI, which became significant on 6 DPI and
continued to increase on 8 DPI (Fig. 2F). The pattern of Abca1 expression correlated
with what was observed in the quantitative proteomics analysis. In control experiments,
no significant increase in the expression of Abca1 was detected on 3 DPI compared to
its expression in mock-infected mice (Fig. S5B). Unexpectedly, transcriptional data of
Abcg5 and Idol exhibit significant downregulation at 6 DPI (Fig. 2G and H), which
anticorrelates with the corresponding data for Abca1, despite reports that all three
proteins are under regulation of LXR in the liver. These data suggest either a differential
mode of cholesterol regulation in IECs during stress conditions or that C. rodentium has
the ability to directly disrupt aspects of cholesterol homeostasis.
C. rodentium infection induces dysbiosis of colon-associated microbiota at 4
DPI. As we found dramatic changes in the metabolic landscape of the epithelium, we
next analyzed whether this affected the composition of the mucosa-associated colonic
microbiome. This revealed a significant decrease in alpha diversity at both 4 and 6 DPI
compared to that in the control mice (Fig. 3A). Weighted and unweighted principal-
coordinate analysis (PCoA) showed significant differences in microbiota compositions
between the conditions, with mock-infected and 6 DPI mice clustering separately and
4 DPI mice split between the two groups (Fig. 3B and C), which is consistent with the
observed mouse-to-mouse variation in CFU counts at 4 DPI (Fig. S6A). Taxonomic
analysis showed that C. rodentium (classified by the Greengenes database as Trabulsiella
[6]) expanded to over 85% of the mucosal bacterial population in 3 out of 5 mice at 4
DPI and in all 4 mice at 6 DPI (Fig. 3D and E). Conversely, analysis of the fecal
microbiome in mock-infected and 4 and 8 DPI samples showed no significant differ-
ences in observed operational taxonomic units (OTUs) (Fig. S6B), and despite a signif-
icant increase in the relative abundances of C. rodentium between mock-infected and
8 DPI mice (Fig. S6D), there was no overall significant change to community compo-
sition (Fig. S6C and D). We previously reported that members of the Enterobacteriaceae
family, undetectable on the colonic mucosa in mock-infected mice, bloom by 8 DPI (6).
Importantly, we observed a bloom in “Enterobacteriaceae” (not further classified) in 4
out of 5 mice as early as the day of colonic colonization (4 DPI) (Fig. 3F). No significant
increase in Enterobacteriaceae was observed in the feces (Fig. S6G), suggesting that
these observed changes are specific to mucosa-associated commensals, and parallel
changes do not occur in the luminal microbiome. Taken together, these results dem-
onstrate that colonic dysbiosis during C. rodentium infection is localized to the mucosa
and occurs as early as 4 DPI, coinciding with low-level C. rodentium colonization of the
colon and changes to the IECs’ metabolic (e.g., cholesterol biogenesis and efflux) and
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bioenergetic (e.g., aerobic glycolysis and downregulation of the TCA cycle and
OXPHOS) activities.
IECs respond to IL-22 from 4 DPI. IL-22 plays a key role in maintaining the
epithelial barrier and preventing C. rodentium dissemination from the gut. Protection of
the mucosal surface is achieved via IL-22 signaling to the IECs, which respond by
phosphorylation of STAT3, cell proliferation, expression of AMPs, and induction of
FIG 3 C. rodentium induces colonic mucosal dysbiosis by 4 DPI. Shown are the results of a16S rRNA gene analysis of the distal colonic mucosal microbiota of
mock-infected mice and at 4 and 6 DPI. (A) Alpha diversity (observed OTUs), showing a significant decrease over time, as analyzed with the Spearman
correlation; (B and C) Jaccard (B) and Bray-Curtis (C) PCoA showing a significant difference in community compositions, analyzed by PERMANOVA; (D) taxonomic
compositions of individual mice; (E and F) relative abundances of species of the Citrobacter/Trabulsiella genus (E) and Enterobacteriaceae family (not further
classified) (F). PC1 and PC2, principal components 1 and 2; *, P  0.05 by the Kruskal-Wallis test with Dunn’s multiple-comparison test. In all panels, a dot or
bar represents an individual mouse.
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nutritional immunity (24). Consistently, STAT3 (enrichment score, 0.69; Benjamini-
Hochberg FDR, 6.84E–03) and a regulator of STAT3, Enhancer of zeste homolog 2
(EZH2) (25) (enrichment score, 0.54; Benjamini-Hochberg FDR, 3.89E–07) (Fig. S4), as
well as E2F1 (enrichment score, 0.69; Benjamini-Hochberg FDR, 0.001) and MYC (en-
richment score, 0.20; Benjamini-Hochberg FDR; 7.08E–18), involved in cell cycle regu-
lation and growth, were predicted to be activated as early as the day of colonic
colonization (4 DPI) (Fig. S4).
We next analyzed temporal changes to cell proliferation in response to C. rodentium
infection by staining colonic sections for the proliferation marker Ki67 and the prolif-
erating cell nuclear antigen (PCNA) (Fig. 4A). This revealed significantly increased
staining for both proliferation markers at 4, 6, and 8 DPI compared to that for
mock-infected mice (Fig. 4B and C). In contrast, no increase in Ki67 staining was
detected at 3 DPI (Fig. S7A and B). Importantly, despite the elevated levels of prolifer-
ation markers, no significant increase in crypt length was observed at the day of colonic
colonization (4 DPI) (Fig. 4D), suggesting that while the activation of cell proliferation
pathways occurs as early as 4 DPI, there is a delay between assembly of the cell
proliferation machinery and development of CCH.
We then monitored IL-22-mediated nutritional immunity responses in a temporal
fashion by measuring LCN-2 and S100A8 levels in feces from individual C. rodentium-
infected mice by ELISA. LCN-2 and S100A8 levels increased significantly from baseline
levels by 4 DPI and continue to increase up to 8 DPI (Fig. 5A and B). To further validate
these findings, we used qRT-PCR to investigate the level of S100A8 expression in IECs
(Fig. 5C). Interestingly, significant induction of S100A8 expression was seen only from
6 DPI in the qRT-PCR data, suggesting that recruited neutrophils might contribute to
the overall S100A8 levels observed in feces at 4 DPI, supported by data showing that
significant numbers of neutrophils are recruited to the epithelium at 4 DPI (26).
Consistent with previous reports (27), expression of the neutrophil chemoattractant
CXCL1 in IECs was significantly induced by 6 DPI, with an increasing trend observed at
4 DPI compared to the trend in mock-infected mice (Fig. 5D). However, the neutrophil
chemoattractant CXCL5 was found significantly upregulated at 4 DPI in the proteomics
data (Fig. 1F). In control experiments, no expression of S100A8 or CXCL1 was detected
on 3 DPI (Fig. S8A and B).
We used Reg3 and iNOS, responsible for producing reactive nitrogen intermedi-
ates, as reporters for IL-22-induced expression of AMPs (28, 29). Employing qRT-PCR, we
observed that Reg3 expression was significantly induced in IECs by the day of colonic
colonization (4 DPI) (Fig. 5E) and continued to increase to the peak of infection.
Furthermore, our results revealed an increasing trend in iNOS expression during C.
rodentium infection which was statistically significant at 6 DPI and 8 DPI (Fig. 5F). These
results suggest that despite IL-22 levels peaking at 4 DPI (18), induction of some
IL-22-mediated genes is significantly induced by this time point and then continues to
increase during infection to 8 DPI. On the other hand, DMBT1, a glycoprotein that has
been shown to inhibit bacterial attachment to IECs (30) and Ido1 (indoleamine 2,3-
dioxygenase 1), a marker for IFN- activity, were significantly induced only at 8 DPI
(Fig. 5G and H). In control experiments, no significant increase in expression of Reg3
or iNOS was detected on 3 DPI (Fig. S8C and D).
C. rodentium reprograms the composition of crypt cell populations. IFN- plays
a role in goblet cell depletion, which itself protects mice from C. rodentium infection
(31). We therefore analyzed the effect of C. rodentium infection on the compositions of
different crypt cell populations over time. Hierarchical clustering and analysis of protein
biomarkers for different epithelial cell types revealed a temporal decrease in goblet
cells, tuft cells, and differentiated IECs during C. rodentium infection (Fig. 6A). To
validate the kinetics of goblet cell depletion, Alcian Blue-periodic acid-Schiff (AB/PAS)
staining, which stains all intracellular mucin glycoproteins, was used to identify and
subsequently count goblet cells in mouse distal colon sections (Fig. 6B). A significant
decrease in the average number of goblet cells per crypt per mouse was observed on
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the day of colonic colonization (4 DPI), in addition to 6 and 8 DPI, compared to the
number in the mock control (Fig. 6C). Consistently, the goblet cell marker protein Clca1
was found to be in lower abundance in the proteome at both 4 and 6 DPI, while the
marker Tff3 was found to be in lower abundance at 6 DPI (Fig. 6D). Notably, MMP9, a
negative regulator of terminal differentiation of goblet cells in the colon, ranked as the
5th-most-upregulated protein at 6 DPI (Fig. 1F), was also in significantly higher abun-
dance at 4 DPI than in mock-infected controls (Fig. 6D). In addition to changes in goblet
cell abundance during infection, there was a decrease in Reg4, a marker for DCS cells
FIG 4 Cell proliferation is initiated before crypt hyperplasia. (A) Representative immunostaining of Ki67 (green), PCNA (red), C. rodentium (white), and DNA
(blue) in colon sections from mice mock infected or infected with C. rodentium at 4, 6, or 8 DPI, as indicated (scale bar  200 m). (B) Crypt lengths measured
from H&E-stained colon sections. (C and D) Fractions of Ki67 (C) or PCNA (D) staining per total crypt length. Each dot represents the mean percentage per mouse
(n 10). Significance was determined by Tukey’s multiple-comparison test. *, P  0.05; **, P  0.01; ***, P  0.001; ****, P  0.0001; ns, not significant.
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FIG 5 Progression of IL-22 responses during the course of in vivo infection. LCN-2 (A) and S100A8 (B) measurements were determined by ELISA on
homogenized stool samples collected at frequent intervals from the day of inoculation to a minimum of 6 DPI. Each dot represents a single mouse.
Significance was determined using the Kruskal-Wallis multiple-comparison test. qRT-PCR analysis of S100A8 (C), CXCL-1 (D), Reg3 (E), Ido1 (F), iNOS (G), and
DMBT1 (H) expression levels in IECs enriched from mock-infected or infected colons at the time points indicated on the x axis. The data are shown as log2
fold changes from the average expression level in uninfected mice from the same biological experiment. Statistical significance was determined by Tukey’s
multiple-comparison test. *, P  0.05; **, P  0.01; ***, P  0.001; ****, P  0.0001.
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from 6 DPI, shown by proteomics and qRT-PCR analyses (Fig. 6E and F). Slc26a3, a
marker for terminally differentiated enterocytes, was also found in lower abundance at
4 and 6 DPI in the proteomic data set (Fig. 6E), although transcripts were significantly
lower only on 8 DPI (Fig. 6G). Consistently, the transcription factor peroxisome
FIG 6 C. rodentium infection induces reprogramming of the epithelium. (A) Intestinal cell type signatures during progression of infection. Shown are relative
expression levels (normalized abundances) of proteins (rows) across samples (columns). Red arrows indicate an observed increasing trend in protein level as
infection progresses, while blue arrows indicate a decrease. Magnitude of change is reflected by the arrow size. Diff., differentiated. (B) Representative images
of AB/PAS staining of mouse colonic section from the distal end. (C) Number of goblet cells per colonic crypt from colonic sections stained with AB/PAS. Each
data point represents the mean number of goblet cells for a single mouse (n 10). Significance was determined by Tukey’s multiple-comparison test. *, P 
0.05; **, P 0.01; ***, P 0.001; ****, P 0.0001. (D) Log2 fold changes at either 4 DPI or 6 DPI, as indicated, compared to levels in mock-infectedmice calculated
from the proteomics data set for the goblet cell markers Clca1, Tff3, and MMP9. (E) Levels of Reg4 and Slc26a3 (differentiated epithelial cell markers as quantified
by proteomics). (F and G) Validation by qRT-PCR of Reg4 (F) and Slc26a3 (G) expression levels.
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proliferator-activated receptor gamma (PPARG), which is involved in promoting the
expression of genes involved in differentiation, was predicted to be significantly
inactivated (enrichment score, 0.51; Benjamini-Hochberg FDR, 2.75E–02) (Fig. S4).
Taken together, these results suggest that while C. rodentium colonizes the top of
the crypts at a low level during the expansion phase of the infection (from the day of
colonic colonization), it temporally reshapes the architecture and cellular composition
all the way down to the stem cell niche, starting with depletion of goblet cells and then
DCS cells and, finally, terminally differentiated enterocytes.
DISCUSSION
Proteomic analysis has been extensively used to study intracellular pathogen-host
interactions during infections (32–35); however, fewer such studies have been con-
ducted on extracellular bacterial infections (36, 37). Furthermore, exploring temporal
changes during in vivo bacterial infection at the protein level is relatively unexplored,
with most temporal proteomics studies focusing on viral infection of cell culture, for
example, hepatitis C virus (HCV) infection (38). Using an isobaric-labeling approach to
map proteome-wide changes during C. rodentium infection of C57BL/6 mice, we have
been able to quantify 9,127 mouse proteins from IECs and to assess significant changes
in abundance during the expansion phase of infection. Further to validating what has
been observed previously at the steady-state phase of C. rodentium infection (6, 39), we
have increased the temporal resolution of this approach and have, unexpectedly,
discovered a rapid onset of changes in IECs occurring immediately upon migration of
bacteria into the colon. Changes to the metabolic profile of the IECs coincided with the
depletion of goblet cells and expansion of Enterobacteriaceae on the day of colonic
colonization (4 DPI).
Surprisingly, despite low levels of shedding and sporadic adhesion at 4 DPI, we
observed significant perturbations in the proteome, including the establishment of an
inverse correlation between repression of central metabolic pathways and upregulation
of processes involved in DNA damage repair and replication. Notably, previous pro-
teomics work revealed similar patterns of upregulation of DNA replication, mismatch
repair, and cell cycle, concomitantly with downregulation of steroid hormone biosyn-
thesis, metabolic pathways, the PPAR signaling pathway, the TCA cycle, and
OXPHOS within a group of cell lines categorized as the colorectal proteomic subtype 1
(40). This group of colorectal cell lines include a wide range of cell types, including
stem, goblet, inflammatory, and TA cells (40–42). Given that this anticorrelation of
processes can be detected within a single cell line and cell lines which correspond with
different cell types, this suggests that the polarization that we observe during in vivo
infection likely occurs within the same cells, as opposed to some processes being
upregulated in one cell type and others being downregulated in another. Furthermore,
the establishment of the inverse-correlation state between proliferation and metabo-
lism is detected as early as the day of colonic colonization (4 DPI), when pathogen
adhesion is sporadic; thus, polarization may be independent of direct bacterial contact
and might represent a global epithelial response to diffusible signals, such as cytokines,
or direct cell-to-cell communication between IECs.
Recent reports suggest involvement of cholesterol in innate immune responses (43).
Furthermore, cholesterol biogenesis was upregulated during C. rodentium infection (6),
resulting in increased serum cholesterol (44). Here, we observed an increased abun-
dance of Abca1 by 4 DPI in the proteomics data and significant transcriptional induc-
tion by 6 DPI. Importantly, other LXR-regulated genes, Abcg5 and Idol, were not
transcriptionally induced and yet were found in higher abundance in the proteomes of
infected IECs than in controls. Similarly, transcription of SREBP2-regulated genes
(Hmgcr, Pcsk9, and Ldlr) was not induced until 8 DPI, although the corresponding
proteins were found in higher abundance in infected IECs than in controls. These results
suggest that LXR and SREBP2 regulation of their target genes in IECs is somewhat
different from their well-studied activities in the liver, the major site where the bodily
cholesterol homeostasis is controlled (23). Furthermore, these data show that as early
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as 4 DPI, both cholesterol biogenesis and efflux proteins are simultaneously in higher
abundance in IECs. However, we still need to determine directionality in terms of
cholesterol control; i.e., it is not apparent if accumulation of hydroxycholesterol due to
cholesterol biogenesis triggers LXR activation or whether efflux, via Abca1 and
Abcg5/8, leads to cholesterol depletion and activation of SREBP2.
Genera of the Enterobacteriaceae family, such as Serratia, Dickeya, and Erwinia, are
able to metabolize cholesterol (45, 46). Consistently, Enterobacteriaceae were found to
bloom on the mucosal surface at 4 DPI concomitantly with upregulation of host
cholesterol biosynthesis and export. Downregulation of -oxidation at 4 DPI, which
increases mucosal oxygenation, likely also favors the expansion of facultative anaer-
obes at the expense of obligate anaerobes. Although quantification of C. rodentium CFU
in stool samples showed a 10-fold increase between 4 and 6 DPI (Fig. 1A), microbiome
analysis showed that C. rodentium represents up to 80 to 90% of the mucosa-associated
bacteria in the majority of mice at 4 DPI (Fig. 3E). Thus, we find that changes to the gut
environment have already excluded the majority of the normal mucosal flora as early
as the day of colonic colonization (4 DPI). Importantly, however, dysbiosis was localized
to the mucosa, with no significant changes in luminal microbiota community structure
(see Fig. S6 in the supplemental material). These results suggest that changes to
metabolism in IECs, such as the switch from aerobic respiration to the Warburg effect,
facilitate the expansion of Enterobacteriaceae, which might cooperate with the innate
immune response in fighting C. rodentium.
We also observed clear IL-22 responses at 4 DPI, illustrated by induced expression of
AMPs (e.g., Reg3) and nutritional immunity (e.g., LCN-2). However, while Tsai and
colleagues have shown upregulation of Claudin-2 at 2 DPI (20), which was found in
higher abundance in the 4 DPI proteome than at other times, none of the responses
measured in this study were induced at 3 DPI, correlating with the absence of visible
C. rodentium in the colon at this time point. This suggests that the alarm in IECs is not
raised during the establishment phase (when C. rodentium resides in the cecum) but
instead as soon as the colon is seeded with C. rodentium at 4 DPI. On the other hand,
both proteomic and transcriptional profiling of Ido1 and iNOS show no statistically
significant increase in levels at 4 DPI compared to levels in mock-infected controls, with
iNOS being significantly induced by 6 DPI in proteomics (log2FC, 2.40) and qRT-PCR
data (Fig. 5G) and Ido1 being significantly induced at 8 DPI (Fig. 5F). These data suggest
that an IFN- response is significantly induced only at the late expansion phase, when
bacterial load is higher, rather than on the first day of colonization (4 DPI).
Importantly, although we observed significant expansion of the Ki67-positive zone,
as well as induction of Slc5A9 (which feeds aerobic glycolysis), at the day of colonic
colonization (4 DPI), no significant CCH was detected at this time point. Taken together,
these results suggest that sensing the presence of a pathogen triggers robust colonic
responses, which might potentially be a preparatory mechanism in case of pathogenic
expansion. Indeed, early proliferation and STAT3 activation have recently been seen in
the small intestine following Listeria monocytogenes mouse infection (47).
It has previously been shown that changes in the cell type populations of the
epithelium occur during C. rodentium infection, with significant reduction of mucin-
containing goblet cells being observed at the peak of infection (1, 8). Here, using a
combination of proteomic, histology, and mRNA expression techniques, we found that
reprogramming of the epithelial layer also occurs as early as 4 DPI, which includes
significant depletion of goblet cells, differentiated epithelial cells, tuft cells, and DCS
cells, with an upregulation in LGR5 cells (Fig. 6A). Importantly, these changes occur in
the absence of significant crypt hyperplasia (Fig. 4D). The decreased abundance of Reg4
and Slc26a3, markers of DCS and differentiated epithelial cells, respectively, was
observed as soon as 4 DPI. Consistently, DCS provides Notch signals to the stem cell
niche, which is critical to terminal cell differentiation (2). However, transcriptionally, a
decline in these markers was seen only at 6 DPI (Notch signals) and 8 DPI (stem cells),
suggesting that protein degradation precedes mRNA turnover. Loss of goblet cells
results in a thinner mucus layer, which has been suggested to coincide with a reduction
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in nutrient availability for C. rodentium, supported by a study where goblet cell
numbers were increased with dibenzazepine and resulted in impaired host defense
(31). Moreover, depletion of goblet cells might provide the commensal Enterobacteri-
aceae access to the surface of IECs, enabling them to expand in a novel niche.
This study has revealed that the early signatures of colonic C. rodentium infection are
reprogramming the metabolic and physiological state of the mucosal surface. Deple-
tion of goblet cells reduces the amount of mucus, which alongside changes to
metabolism and oxygen availability, allows accessibility of Gram-negative commensals
to the mucosa, followed by expansion, which might assist the host in expelling the
pathogen. Accordingly, we report for the first time that, parallel to innate immune
responses, there are inherent IEC and microbiome responses to infection at the onset
of mouse colonic infection. Considering that C. rodentium, EPEC, and EHEC share an
infection strategy and virulence factors, the intestinal responses in mice infected with
C. rodentium likely reflect human responses to infection with extracellular pathogens.
MATERIALS AND METHODS
Bacterial strains. Citrobacter rodentium strain ICC169 (7, 48) was grown in Miller lysogeny broth (LB;
Invitrogen) or on LB solidified with 3.7% agar, supplemented with ampicillin (100 g/ml), kanamycin
(50 g/ml), nalidixic acid (NAL) (30 g/ml), or gentamicin (Gm) (10 mg/ml), as required, and grown
overnight at 37°C with shaking at 200 rpm (liquid cultures) or stationary (for plates).
Animals procedures. All animal experiments were performed in accordance with the Animals
Scientific Procedures Act of 1986 and were approved by the local Ethical Review Committee and UK
Home office guidelines. Experiments were designed in agreement with the ARRIVE guidelines (49) for the
reporting and execution of animal experiments. Specific-pathogen-free female C57BL/6 mice (18 to 20 g)
were purchased from Charles River, London, United Kingdom. All mice were housed in individually
HEPA-filtered cages with sterile bedding (processed corncobs, grade 6), nesting (LBS Serving technology),
and free access to sterilized food (LBS Serving technology) and water. For each experiment, 5 mice were
randomly assigned to each group.
Oral gavage of mice and CFU count. Overnight cultures of C. rodentium strain ICC169 were pelleted
and subsequently concentrated 10-fold in sterile phosphate-buffered saline (PBS) (5 109 CFU/ml).
Mice were inoculated by oral gavage with 200 l of the concentrated inoculum, and the number of
viable bacteria used as inoculum was determined by retrospective plating onto LB agar containing NAL.
Mock-treated mice were orally gavaged with 200 l PBS. Stool samples were collected daily after
inoculation, and the number of viable bacteria per gram of stool was determined by serial dilution and
plating onto LB agar containing NAL.
Extraction of enterocytes. At 4 or 6 DPI, a 4-cm segment of terminal colon was cut longitudinally,
placed in 4 ml enterocyte dissociation buffer (1 Hanks’ balanced salt solution without Mg and Ca,
containing 10 mM HEPES, 1 mM EDTA, and 5 ml/ml 2--mercaptoethanol), and incubated at 37°C with
shaking for 45 min. The remaining tissue was removed and stored at 80°C, and lifted enterocytes were
collected by centrifugation (2,000 g for 10 min), followed by two PBS washes. Enterocyte pellets were
stored at 80°C for either proteomics or qRT-PCR experiments.
Histological analysis. The distal 0.5 cm of the colon was fixed in 4% paraformaldehyde (PFA) for
2.5 h and then submersed in 70% ethanol. Fixed tissues were processed, paraffin embedded, and
sectioned at 5 m by Lorraine Lawrence (histology facility, Imperial College London). Formalin-fixed,
paraffin-embedded (FFPE) sections were then stained with either hematoxylin and eosin (H&E) or Alcian
blue and periodic acid-Schiff (AB/PAS) stain, using standard techniques, or processed for immunofluo-
rescence.
H&E-stained sections were analyzed using a 20 lens objective on the Zeiss Axio Observer Z1
microscope. At least 20 well-oriented crypts from each section from each individual mouse were
measured, and an average crypt length for each mouse was calculated, using ZEN 2.3 Lite software
(Zeiss). Similarly, Ki67 staining was also measured by this method and divided by the total length of the
crypt to calculate the percentage of Ki67 staining. The same protocol was used to analyze PCNA staining
in the crypt. The density of goblet cells was calculated by counting the number of goblet cells per crypt
and measuring the total crypt length.
FFPE sections were dewaxed by submersing them in Histo-Clear solution twice for 10 min, 100%
ethanol (EtOH) twice for 10 min, 95% EtOH twice for 3 min, 80% EtOH once for 3 min, and PBS-0.1%
Tween 20-0.1% saponin (PBS-TS) twice for 3 min. Subsequently, sections were then heated for 20 min in
demasking solution (0.3% trisodium citrate-0.05% Tween 20 in distilled H2O). Once cooled, slides were
first blocked in PBS-TS supplemented with 10% normal donkey serum (NDS) for 20 min in a humid
chamber, before being incubated with primary antibody diluted in PBS-TS with 10% NDS for 1 h. Ki67
(Abcam) was diluted 1:50, PCNA (Abcam) was diluted 1:500, and intimin 280B against porcine EPEC (50)
was diluted at 1:50. Slides were rinsed twice for 10 min each time in PBS-TS, followed by incubation with
secondary antibodies, DAPI (4=,6-diamidino-2-phenylindole), and phalloidin, which was again diluted in
PBS-TS supplemented with NDS for 1 h. All secondary antibodies (Jackson Immunoresearch) were used
at 1:100, while the reagents DAPI (Thermo Fisher) and phalloidin-iFluor 647 conjugate (Thermo Fisher)
were used at 1:1,000 and 1:100, respectively. Washing steps were repeated before slides were mounted
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with ProLong Gold antifade mountant (Thermo Fisher Scientific). Slides were imaged the subsequent day
using a Zeiss Axio Observer Z1 microscope with a 20 lens objective. Images were acquired with
AxioVision 4.3 software and subsequently analyzed using ImageJ (Fiji).
LCN-2 and S100A8 ELISA. Stool samples were homogenized in PBS with 0.1% Tween 20 (PBST)
using a vortex machine for 15 min. Samples were centrifuged at 16,000 rpm for 10 min, and the
supernatant was extracted and stored at 80°C. LCN-2 concentration was determined using a DuoSet
mouse lipocalin-2 ELISA or DuoSet mouse S100A8 ELISA (R&D Systems), according to the manufacturer’s
instructions.
Quantitative real-time RT-PCR. RNA from enriched IECs was isolated with an RNeasy minikit
(Qiagen) by following the manufacturer’s instructions. RNA was treated with RQ1 RNase-free DNase
(Promega), and subsequently, cDNA was synthesized using a Moloney murine leukemia virus reverse
transcription kit (Promega). Quantitative RT-PCR was performed using Fast SYBR green master mix
(Thermo Fischer Scientific) and different primer pairs (see Table S2 in the supplemental material).
Sample preparation for TMT labeling. Both IEC pellets isolated from mice and CMT-93 cell pellets
were dissolved in 150 l 0.1 M triethylammonium bicarbonate (TEAB), 0.1% SDS, 10% isopropanol on ice,
assisted with pulsed probe sonication. Samples were subsequently boiled at 90°C for 5 min on a shaking
device at 300 rpm. Protein concentration was measured with the Quick Start Bradford protein assay
(Bio-Rad) according to the manufacturer’s instructions. Aliquots containing 100 g of total protein, with
an equal contribution from each individual mouse within the group, were prepared for trypsin digestion.
Samples were reduced with 5 mM tris-2-carboxyethyl phosphine (TCEP) and alkylated with 10 mM
iodoacetamide (IAA). Proteins were then digested by adding 75 ng/l trypsin to each sample and
incubating the samples overnight. The resultant peptides were diluted up to 100 l with 0.1 M TEAB
buffer and labeled with a tandem mass tag (TMT) multiplex reagent vial (Thermo Scientific) according to
the manufacturer’s instructions. Hydroxylamine was used to quench the reaction, and then all 11 samples
were combined in equal amounts to a single tube. The sample was then dried with a centrifugal vacuum
concentrator.
Basic reverse-phase peptide fractionation and LC-MS/MS analysis. Offline high-pH reverse-phase
(RP) peptide fractionation was performed using the Waters XBridge C18 column (2.1 by 150 mm, 3.5 mm)
on a Dionex Ultimate 3000 high-performance liquid chromatograph (HPLC) system. Mobile phase A was
0.1% ammonium hydroxide, and mobile phase B was 100% acetonitrile, 0.1% ammonium hydroxide. The
TMT-labeled peptide mixture was reconstituted in 100 ml mobile phase A and was fractionated using a
multistep gradient elution method at 0.2 ml/min as follows: isocratic for 5 min at 5% phase B, gradient
for 35 min to 35% phase B, gradient to 80% phase B in 5 min, isocratic for 5 min, and reequilibrated to
5% phase B. Fractions were collected every 30 s and vacuum dried. LC-MS/MS analysis was performed on
the Dionex Ultimate 3000 system coupled with the Orbitrap Fusion mass spectrometer (Thermo
Scientific). Each peptide fraction was reconstituted in 40 l 0.1% formic acid, and 7 l was loaded to the
Acclaim PepMap 100, 100-m by 2-cm, 5-m, 100-Å C18 trapping column at a 10-l/min flow rate. The
sample was then subjected to a gradient elution on the Acclaim PepMap rapid-separation LC (75 m by
50 cm, 2 m, 100 Å) C18 capillary column at 45°C. Mobile phase A was 100% H2O, 0.1% formic acid, and
mobile phase B was composed of 80% acetonitrile, 0.1% formic acid. The gradient separation method at
a flow rate of 300 nl/min was as follows: gradient for 90 min from 10% to 38% phase B and for 10 min
up to 95% phase B, isocratic for 5 min at 95% B, reequilibrated to 5% phase B in 5 min, and isocratic for
10 min at 10% phase B. Precursors between 375 and 1,500m/z were selected, with mass resolution of
120,000, automatic gain control (AGC) of 4 105, and IT (injection time) of 50 ms, with the top speed
mode in 3 s, and the precursors were isolated for collision-induced dissociation (CID) fragmentation with
a quadrupole isolation width of 0.7 Th (Thomson unit). Collision energy was set at 35%, with AGC at
1 104 and IT at 50 ms. MS3 quantification was obtained with higher-energy collisional dissociation
(HCD) fragmentation of the top 7 most abundant CID fragments isolated with synchronous precursor
selection (SPS). Quadrupole isolation width was set at 0.7 Th, collision energy was applied at 65%, and
the AGC setting was at 1 105 with IT at 105 ms. The HCD MS3 spectra were acquired for the mass range
100 to 500 with a resolution of 50,000. Targeted precursors were dynamically excluded for further
isolation and activation for 45 s with 7-ppm mass tolerance.
Database search and protein quantification. The SEQUEST-HT search engine was used to analyze
the acquired mass spectra in Proteome Discoverer 2.1 (Thermo Scientific) for protein identification and
quantification. The precursor mass tolerance was set at 20 ppm, and the fragment ion mass tolerance was
set at 0.5 Da. Spectra were searched for fully tryptic peptides with maximum 2 mis-cleavages. TMT6plex
at the N terminus/K and carbamidomethyl at the C terminus were defined as static modifications.
Dynamic modifications included oxidation of M and deamidation of N/Q. Peptide confidence was
estimated with the Percolator node. The peptide FDR was set at 0.01, and validation was based on the
q value and a decoy database search. All spectra were searched against UniProt reference proteomes of
Mus musculus and C. rodentium protein entries. The reporter ion quantifier node included a TMT 11-plex
quantification method with an integration window tolerance of 15 ppm and integration method based
on the most confident centroid peak at the MS3 level. Only unique peptides were used for quantification,
with protein groups considered for peptide uniqueness. Peptides with an average reported signal-to-
noise ratio of 3 were used for protein quantification. The enterocytes obtained from mock-infected
mice were used as controls for log2 ratio calculations.
Data analysis. Differential expression P values were calculated using a single-sample t test in the
Perseus proteomics tool (51). Average log2 fold changes were used for duplicate measurements of a
single time point. KEGG pathway and GOBP slim pathway enrichment analysis was performed with the
1D-annotation enrichment method (52). Terms with significant positive enrichment were addressed as
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upregulated and those with negative enrichment as downregulated. All terms were filtered for a
Benjamini-Hochberg FDR of 0.05 or an FDR of 0.1.
16S rRNA gene sequencing and microbiome analysis. Upon necroscopy, 1 cm of distal colon was
immediately frozen and stored at 80°C. DNA was extracted using a Power Soil kit (MO Bio). The 16S V4
region was amplified using 515F/806R primers and sequenced using 2 250-bp paired-end sequencing
(Illumina MiSeq). Sequences were analyzed using the Qiime2 (Quantitative Insights into Microbial
Ecology 2; http://www.qiime2.org) analysis pipeline (53). Briefly, FASTA-quality files and a mapping file
indicating the barcode sequence corresponding to each sample were used as inputs. Sample reads were
separated according to their barcode. Reads were denoised, low-quality reads were trimmed, and paired
reads were assembled into longer reads using the DADA2 plugin (54). Samples with less than 15,000
quality reads were excluded from downstream analysis. Taxonomy was assigned using a naive Bayes
classifier trained against the Greengenes database (version 13_8), trimmed to contain only the V4
hypervariable region and preclustered at 99% sequence identity. For beta-diversity analysis, weighted
(Bray-Curtis) and unweighted (Jaccard) distance measurements were plotted according to the two
principal coordinates, and significance between group distances was analyzed using an all-group
permutational multivariate analysis of variance (PERMANOVA).
Statistical analysis. Data were analyzed by a paired two-tailed Student t test or one-way ANOVA
with Tukey’s multiple-comparison posttest, as detailed in the figure legends. PRISM 7 (GraphPad) was
used to plot line graphs, bar charts, and dot plots. Volcano plots and distribution plots were drawn in
RStudio with the ggplot2 and ggrepel packages.
Data availability. The mass spectrometry proteomics data have been deposited in the ProteomeX-
change Consortium via the PRIDE partner repository (55) with the data set identifier PXD012031.
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